Rosetta Capital Limited

Our investment approach is global, building leading healthcare companies and ground breaking technologies with the potential to enhance human lives. Our primary focus is direct secondary transactions, offering adaptable liquidity solutions to investors and corporations.

Rosetta is a specialised UK-based venture capital firm focused on the life sciences and medical device sectors.

With a history spanning 20+ years, Rosetta has engaged in 50+ venture investments through direct secondary transactions. As secondary investors, we address the needs of investors or corporations aiming to divest investment assets, together with those seeking additional capital and resources to enhance investment strategies. We inject fresh capital into companies during follow-on financings, providing crucial support during pivotal growth stages. Our seasoned team collaborates strategically with portfolio company boards, management teams, and co-investors, facilitating successful corporate partnerships, IPOs, and trade sales. Our goal is to enhance the value of investments and contribute to the advancement of healthcare and technology